Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Retained Earnings (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Retained Earnings for 16 consecutive years, with -$11.7 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 92.61% to -$11.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.7 million through Dec 2025, up 92.61% year-over-year, with the annual reading at -$11.7 million for FY2025, 92.61% up from the prior year.
  • Retained Earnings for Q4 2025 was -$11.7 million at Harvard Bioscience, up from -$12.4 million in the prior quarter.
  • The five-year high for Retained Earnings was -$11.7 million in Q4 2025, with the low at -$208.4 million in Q1 2025.
  • Average Retained Earnings over 5 years is -$88.7 million, with a median of -$133.1 million recorded in 2021.
  • The sharpest move saw Retained Earnings tumbled 1013.53% in 2024, then soared 92.61% in 2025.
  • Over 5 years, Retained Earnings stood at -$132.7 million in 2021, then dropped by 7.17% to -$142.2 million in 2022, then skyrocketed by 90.02% to -$14.2 million in 2023, then crashed by 1013.53% to -$158.0 million in 2024, then skyrocketed by 92.61% to -$11.7 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$11.7 million, -$12.4 million, and -$11.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.